Clovis Oncology, Inc. Exchange Rate Effect on Cash
Clovis Oncology, Inc. reported Exchange Rate Effect on Cash of -$3.86 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations · last filed 2022-11-09
- Clovis Oncology, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for the quarter ending 2022-03-31 was -$487.00K.
- Clovis Oncology, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for the quarter ending 2021-03-31 was -$675.00K.
- Clovis Oncology, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for the quarter ending 2020-03-31 was -$481.00K.
- Clovis Oncology, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for the quarter ending 2019-03-31 was -$64.00K, a 125.20% decline year-over-year.
- Clovis Oncology, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for fiscal 2021 was -$589.00K, a 151.13% decline from fiscal 2020.
- Clovis Oncology, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for fiscal 2020 was $1.15M, a 302.80% increase from fiscal 2019.
- Clovis Oncology, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for fiscal 2019 was $286.00K.
- Clovis Oncology, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents, including disposal group and discontinued operations for fiscal 2018 was -$547.00K, a 158.01% decline from fiscal 2017.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations 12 month |
|---|---|---|---|---|
| 2022-09-30 | -$3.86M 10-Q · filed 2022-11-09 | |||
| 2022-06-30 | -$2.12M 10-Q · filed 2022-08-08 | |||
| 2022-03-31 | -$487.00K 10-Q · filed 2022-05-05 | |||
| 2021-12-31 | -$589.00K 10-K · filed 2022-02-24 | |||
| 2021-09-30 | -$313.00K 10-Q · filed 2022-11-09 | |||
| 2021-06-30 | -$542.00K 10-Q · filed 2022-08-08 | |||
| 2021-03-31 | -$675.00K 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | $1.15M 10-K · filed 2022-02-24 | |||
| 2020-09-30 | $1.15M 10-Q · filed 2021-11-03 | |||
| 2020-06-30 | -$304.00K 10-Q · filed 2021-08-04 | |||
| 2020-03-31 | -$481.00K 10-Q · filed 2021-05-05 | |||
| 2019-12-31 | $286.00K 10-K · filed 2022-02-24 | |||
| 2019-09-30 | -$240.00K 10-Q · filed 2020-11-05 | |||
| 2019-06-30 | $43.00K 10-Q · filed 2020-08-07 | |||
| 2019-03-31 | -$64.00K 10-Q · filed 2020-05-06 | |||
| 2018-12-31 | -$547.00K 10-K · filed 2021-02-25 | |||
| 2018-09-30 | -$286.00K 10-Q · filed 2019-11-07 | |||
| 2018-06-30 | -$207.00K 10-Q · filed 2019-08-02 | |||
| 2018-03-31 | $254.00K 10-Q · filed 2019-05-07 | |||
| 2017-12-31 | $943.00K 10-K · filed 2020-02-26 | |||
| 2017-09-30 | $886.00K 10-Q · filed 2018-11-01 | |||
| 2017-06-30 | $565.00K 10-Q · filed 2018-08-02 | |||
| 2016-12-31 | -$365.00K 10-K · filed 2019-02-28 |